Gene · 3113
NIH grants1,839
NIH grants whose papers are about the gene, through NIH's grant-paper links.
841 to 860 of 1,839
Download this page as JSON| Grant | Title | HLA-DPA1 papers | Newest fiscal year |
|---|---|---|---|
| U24CA210972 | Proteogenomic Data Analysis for Cancer Systems Biology and Clinical Translation | 1 | 2020 |
| U24CA210979 | Integrated high throughput proteogenomic data analysis center for CPTAC | 1 | 2020 |
| U24CA210986 | Center of Excellence for High Throughput Proteogenomic Characterization | 1 | 2020 |
| U24CA210993 | Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine | 1 | 2020 |
| U2CEB021881 | Admin Supp to: The Health ePeople Resource for Mobilized Research | 1 | 2020 |
| UG3TR002884 | Microfluidics Array Based Sorting, Isolation, and RNA Analysis in Single Extracellular V csicles | 1 | 2020 |
| UH2AI144434 | Airway Dendritic Cells in the Allergic Asthma Phenotype | 1 | 2020 |
| UH2AR067676 | Stanford Technology Accelerating Medicines Partnership Center | 1 | 2020 |
| UH2AR067679 | Accelerating Medicines Partnership in RA and Lupus: Network Sites (UH2/UH3) | 1 | 2020 |
| UH2AR067681 | Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established Disease | 1 | 2020 |
| UH2AR067688 | PEARL: Pathway Exploration and Analysis in Renal Lupus | 1 | 2020 |
| UH2AR067689 | Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium | 1 | 2020 |
| UH2AR067690 | Cellular Dynamics at the Synovium-Bone interface in RA | 1 | 2020 |
| UH2AR067691 | Molecular Pathways in Treatment Response and Flare in RA | 1 | 2020 |
| UH2AR067694 | Molecular and Cellular Dissection of Early Rheumatoid Arthritis | 1 | 2020 |
| UM2AR067678 | AMP RA/SLE Leadership Center | 1 | 2020 |
| ZIAAG000951 | Genetic Analysis of Dementia Disorders Neuropathologically Between Alzheimer's and Parkinson's Disease | 1 | 2020 |
| ZIAAR041153 | Outcomes in Rheumatic Diseases | 1 | 2020 |
| ZIABC011033 | Mechanisms of MHC Class II Association with Plasma Membrane Microdomains | 1 | 2020 |
| ZIACT000265 | Simulating Protein Structures, Complexes, And Dynamics | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/grants?page=43